Search Results - "Ell, Peter J."

Refine Results
  1. 1
  2. 2
  3. 3

    Fusion of Metabolic Function and Morphology: Sequential [18F]Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Studies Yield New Insights Into the Natural History of Bone Metastases in Breast Cancer by Du, Yong, Cullum, Ian, Illidge, Tim M, Ell, Peter J

    Published in Journal of clinical oncology (10-08-2007)
    “…By monitoring bone metastases with sequential [(18)F]fluorodeoxyglucose positron-emission tomography/computed tomography ([(18)F]FDG-PET/CT) imaging, this…”
    Get full text
    Journal Article
  4. 4

    Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas by Wild, Damian, Christ, Emanuel, Caplin, Martyn E, Kurzawinski, Tom R, Forrer, Flavio, Brändle, Michael, Seufert, Jochen, Weber, Wolfgang A, Bomanji, Jamshed, Perren, Aurel, Ell, Peter J, Reubi, Jean Claude

    Published in Journal of Nuclear Medicine (01-07-2011)
    “…Glucagon-like peptide-1 (GLP-1) receptor imaging is superior to somatostatin receptor subtype 2 (sst(2)) imaging in localizing benign insulinomas. Here, the…”
    Get full text
    Journal Article
  5. 5

    Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT by Wild, Damian, Wicki, Andreas, Mansi, Rosalba, Béhé, Martin, Keil, Boris, Bernhardt, Peter, Christofori, Gerhard, Ell, Peter J, Mäcke, Helmut R

    Published in Journal of Nuclear Medicine (01-07-2010)
    “…Strong overexpression of glucagonlike peptide-1 (GLP-1) receptors in human insulinoma provides an attractive target for imaging. The first clinical trials…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Non-[18 F]FDG PET in clinical oncology by Groves, Ashley M, Dr, Win, Thida, MRCP, Haim, Simona Ben, Prof, Ell, Peter J, Prof

    Published in The lancet oncology (01-09-2007)
    “…Summary PET is an exquisitely sensitive molecular imaging technique using positron-emitting radioisotopes coupled to specific ligands. Many biological targets…”
    Get full text
    Journal Article
  10. 10

    Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study by Barkus, Emma, Morrison, Paul D, Vuletic, D, Dickson, John C, Ell, Peter J, Pilowsky, Lyn S, Brenneisen, Rudolf, Holt, David W, Powell, John, Kapur, Shitij, Murray, Robin M

    Published in Journal of psychopharmacology (Oxford) (01-11-2011)
    “…Intravenous (IV) Δ9-tetrahydrocannabinol (THC) induces transient psychotic symptoms in healthy subjects and in schizophrenic patients, but the psychotomimetic…”
    Get full text
    Journal Article
  11. 11

    Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy—a [123I]CNS-1261 SPET study by Stone, James M., Erlandsson, Kjell, Arstad, Erik, Squassante, Lisa, Teneggi, Vincenzo, Bressan, Rodrigo A., Krystal, John H., Ell, Peter J., Pilowsky, Lyn S.

    Published in Psychopharmacologia (01-04-2008)
    “…Rationale Ketamine induces effects resembling both positive and negative psychotic symptoms of schizophrenia. These are thought to arise through its action as…”
    Get full text
    Journal Article
  12. 12

    The Role of Positron Emission Tomography in the Management of Pancreatic Cancer by Pakzad, Farrokh, Groves, Ashley M., Ell, Peter J.

    Published in Seminars in nuclear medicine (01-07-2006)
    “…The role of positron emission tomography (PET) and PET/computed tomography (CT) in the assessment of a patient presenting with cancer of the pancreas is…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    CT pulmonary angiography versus ventilation-perfusion scintigraphy in pregnancy: implications from a UK survey of doctors' knowledge of radiation exposure by Groves, Ashley M, Yates, Stuart J, Win, Thida, Kayani, Irfan, Gallagher, Ferdia A, Syed, Rizwan, Bomanji, Jamshed, Ell, Peter J

    Published in Radiology (01-09-2006)
    “…To prospectively investigate the fetal dosimetry knowledge of health care professionals involved in the management of pulmonary embolism. One hundred sixty-one…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors by Wild, Damian, Bomanji, Jamshed B, Benkert, Pascal, Maecke, Helmut, Ell, Peter J, Reubi, Jean Claude, Caplin, Martyn E

    Published in The Journal of nuclear medicine (1978) (01-03-2013)
    “…Somatostatin receptor PET tracers such as [(68)Ga-DOTA,1-Nal(3)]-octreotide ((68)Ga-DOTANOC) and [(68)Ga-DOTA,Tyr(3)]-octreotate ((68)Ga-DOTATATE) have shown…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Tumor Heterogeneity and Permeability as Measured on the CT Component of PET/CT Predict Survival in Patients with Non―Small Cell Lung Cancer by WIN, Thida, MILES, Kenneth A, ELL, Peter J, GROVES, Ashley M, JANES, Sam M, GANESHAN, Balaji, SHASTRY, Manu, ENDOZO, Raymondo, MEAGHER, Marie, SHORTMAN, Robert I, WAN, Simon, KAYANI, Irfan

    Published in Clinical cancer research (01-07-2013)
    “…We prospectively examined the role of tumor textural heterogeneity on positron emission tomography/computed tomography (PET/CT) in predicting survival compared…”
    Get full text
    Journal Article